Medical Tech Outlook

Ortho Ried has been recognized as one of the Top Regenerative Medicine Solutions Providers in Europe by Medical Tech Outlook. Ortho Ried is a top-tier clinical facility specializing in regenerative therapies like stem cell therapy, ACP/PRP, magnetic field therapy, high-energy extracorporeal shockwave therapy, genetic tests, orthomolecular therapy, and a range of anti-pain infusions and joint infiltrations tailored to treat diverse musculoskeletal conditions. When necessary, Dr. Tomazi also offers surgical treatments such as joint replacement surgery and arthroscopy at the local Hospital. Dr. Tomazi is dedicated to advancing regenerative therapies and supporting individuals on their journey to painless healthcare. "A single treatment can bring up to 80 percent improvement in joint function and pain reduction for the duration of up to five years," says Thiago Tomazi, Orthopaedic and Traumatology Specialist. The article will also be featured in the forthcoming special print edition of Regenerative Medicine 2024. Read More: https://lnkd.in/gFrcpD6g #minimallyinvasive #jointrepair #painrelief #arthritis #nonsurgicaloption

Eric Huang, Engineering Manager at Alcon Contributed an article "Optimizing Molding Processes and Driving R&D Excellence" "Open-mindedness and embracing challenges are essential to aligning R&D with broader business goals," says Eric Huang. Read More: https://lnkd.in/gSieJiGt #simulations #costreduction #automation #molddesign #collaboration

Simon Davies, Executive Director of Teen Cancer America Contributed an article "Cancer Diagnostics from a patient advocate's perspective" “The development of cancer vaccines and the use of AI in diagnostics are already making a significant impact, offering hope for more effective and personalized treatments for young cancer patients,” says Simon Davies. The article will also be featured in the forthcoming special print edition of In Vitro Diagnostic 2024. Read More: https://lnkd.in/geKrhAnN #cancercare #liquidbiopsies #cancervaccines #hpvvaccines #cancerresearch

Research Collective has been recognized as one of the Top Medical Device Design and Development Services Providers by Medical Tech Outlook. Research Collective specializes in developing safe, user-friendly medical products by identifying market needs, reducing risks, ensuring regulatory compliance, and preventing misuse, recalls, and brand damage. Their holistic approach ensures innovative, effective products ready for successful market entry. “Our aim is to make it easy for the user to do the right thing and make it impossible for the user to do the wrong thing,” says Russ Branaghan, PhD President and Co-Founder. The article will also be featured in the forthcoming special print edition of Medical Device Design and Development 2024. Read More: https://lnkd.in/gAD5Xw-6 #medicaldevicedevelopment #fdahumanfactorsguidance #iecstandards #aamistandards #mhrarequirements

In 1 week Boston will become the epicenter of patient-focused healthcare! On October 15-16, join industry leaders, patient advocates, and healthcare innovators at Pharma & Patient USA 2024 https://bit.ly/4di3I0u Learn, network, and leave with strategies to truly put patients at the heart of your mission.

Engineered Tissue Solutions (ETS) Wound Care has been recognized as the Wound Care Solution Company Of The Year by Medical Tech Outlook. Engineered Tissue Solutions (ETS) is an innovative wound care company that redefines complex and chronic wound healing with borate-based bioactive glass technology. The company has developed a synthetic skin substitute, Mirragen that seamlessly conforms to any wound bed, reduces healing time, minimizes treatment costs, and improves patient outcomes. “Three critical barriers still persist today when it comes to healing complex wounds: a lack of wound bed activity to create sufficient quality tissue and angiogenesis, the risk of infection due to potential bioburden in the wound bed, and the need for multiple products on the shelf to fit different wound sizes and depths. Our groundbreaking solution aims to address all three of these challenges in a way that no other skin substitute can,” says AJ Ford, CEO. The article will also be featured in the forthcoming special print edition of Wound Care 2024. Read More: https://lnkd.in/gvK4AwNF #bioactiveglasstechnology #syntheticskinsubstitute #woundbedactivity #chronicwoundhealing

Exceed KPIs Without Sacrificing Relationships How can we meet the needs of HCPs while satisfying new customer groups? Discover actionable insights at Reuters Events: Pharma Customer Engagement Europe 2024 in London. https://lnkd.in/d-4Rh3HC engagement- europe?utm_source=mp_medtechoutlook_wk5&utm_medium=socials&utm_campaig n=6209 Learn from leaders from AstraZeneca, Roche, Daiichi Sankyo and more! #KPIs #CustomerEngagement #REcustomerEU24

SYPHILIS HEALTH CHECK™ has been recognized as one of the Top Diagnostics Test Kits Provider by Medical Tech Outlook. Diagnostics Direct LLC transforms syphilis testing with Syphilis Health Check (SHC), combating the resurgence of this once nearly eradicated disease, with a focus on congenital syphilis. An FDA-cleared, CLIA-waived rapid test, SHC offers accurate results in just 10 minutes from a single drop of whole blood. Affordable and user-friendly, it empowers healthcare providers and individuals, transforming public health by enabling timely screenings and interventions. "Syphilis Health Check™ is making syphilis screening seamless. Testing is conducted within minutes with just a fingerstick and one drop of whole blood. It is super easy, swift, and just two steps to deliver crucial results", says Norman Proulx, CEO, president and co-founder. The article will also be featured in the forthcoming special print edition of Diagnostics Test Kits 2024. Read More: https://lnkd.in/gYt_5p5r #congenitalsyphilis #rapidsyphilistesting #igmandigantibodies #diagnosticsinnovation

In just 2 weeks, get ready to be inspired by the most influential voices in pharma and patient advocacy! At Pharma & Patient USA 2024, you'll hear from renowned speakers including:  Anne White, EVP & President of Lilly Neuroscience, Eli Lilly Jon Zwinski, General Manager, Chiesi USA Dr. Michael Ybarra, MD, Chief Medical Officer, PhRMA And many more! Don't miss this opportunity to gain actionable insights and learn from the best in the industry. Register now and take your patient-centric passions to the next level! https://bit.ly/4di3I0u

anovora has been recognized as one of the Top Medtech Companies by Medical Tech Outlook. Anovora provides clinical researchers and medical professionals with comprehensive cloud-based technologies for real-time data analyses. "With innovative business solutions that scale for the enterprise, we provide subject matter expertise and creativity to our clients," says Henry Wilson, Managing Director of Anovora. Read More: https://lnkd.in/geYdsYXM #smarterdrugs #cloudbasedwearables #clinical360ºview